M16-833
ClinicalTrials.gov NCT03926169
Research payments
$1,306,697
Through program year 2020, $1,306,697 in research payments was reported against M16-833, across 221 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03926169
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $1,158,946 | 196 |
| 2019 | Research | $147,751 | 25 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Benjamin Ehst Portland, OR Named on 18 payments
- Dowling Stough Hot Springs, AR Named on 17 payments
- Emanual Maverakis Sacramento, CA Named on 17 payments
- Navid Ezra Thousand Oaks, CA Named on 17 payments
- Raja Sivamani Sacramento, CA Named on 14 payments
- Joel Schlessinger Omaha, NE Named on 13 payments
- Michael Payette Farmington, CT Named on 13 payments
- Syed Hamzavi Clinton Twp, MI Named on 12 payments
- Steven Kempers Fridley, MN Named on 12 payments
- Jeffrey Crowley Bakersfield, CA Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.